Demographic and Clinical Characteristics of Hospitalized Patients with Type 2 Diabetes Mellitus and Comorbid Parkinson’s Disease in Spain: A Nationwide Observational Study (2017-2023).

Publication date: Jul 02, 2025

Background/Objectives: Type 2 diabetes mellitus (T2DM) and Parkinson’s disease (PD) are two highly prevalent chronic conditions that often coexist in older adults. Their interaction may influence clinical outcomes, particularly during external stressors such as the COVID-19 pandemic. This study aimed to assess the prevalence and temporal trends of PD among hospitalized patients with T2DM in Spain (2017-2023), evaluate sex-based differences in clinical characteristics and outcomes, examine the impact of the COVID-19 pandemic, and identify predictors of PD diagnosis and in-hospital mortality (IHM). Methods: We conducted a retrospective, nationwide study using the Spanish National Hospital Discharge Database (RAE-CMBD). Adults aged ≥40 years hospitalized with T2DM were included. PD cases were identified using ICD-10 codes. Joinpoint regression assessed temporal trends, and multivariable logistic regression identified factors associated with PD and IHM. Results: Among 5. 1 million T2DM-related hospitalizations, 107,931 (2. 41%) involved PD. PD prevalence increased over time, particularly among women. Men accounted for most PD cases and were younger than their female counterparts. Depression and anxiety were more frequent in women and associated with PD in both sexes. IHM peaked at 14. 6% in 2020, coinciding with the COVID-19 outbreak. Predictors of IHM included older age, higher comorbidity burden, dementia, and COVID-19 diagnosis. Conclusions: The coexistence of PD and T2DM in hospitalized patients is associated with clinical complexity and increased mortality. Personalized, multidisciplinary care is essential to address sex-specific patterns, psychiatric comorbidities, and vulnerability to systemic stressors.

Open Access PDF

Concepts Keywords
Diabetes comorbidity
Hospitalizations COVID-19
Parkinson hospitalization
Sex in-hospital mortality
Parkinson’s disease
sex
Type 2 diabetes mellitus

Semantics

Type Source Name
disease MESH Type 2 Diabetes Mellitus
disease MESH Parkinson’s Disease
disease MESH chronic conditions
disease MESH COVID-19 pandemic
disease MESH Depression
disease MESH anxiety
disease MESH comorbidity
disease MESH dementia
disease MESH Diabetes Mellitus
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH cognitive decline
disease MESH insulin resistance
pathway KEGG Insulin resistance
disease MESH glucose intolerance
disease MESH multiple chronic conditions
disease MESH inflammation
disease MESH oxidative stress
disease MESH neuroinflammation
drug DRUGBANK Dextrose unspecified form
disease MESH death
disease MESH tremor
disease MESH gait
disease MESH clinical progression
disease MESH symptom burden
disease MESH Parkinsonian syndromes
disease MESH Progressive Supranuclear Palsy
disease MESH Corticobasal syndrome
disease MESH personality disorders
disease MESH sleep disorders
disease MESH alcohol related disorders
disease MESH vascular dementia

Original Article

(Visited 3 times, 1 visits today)